TherapeuticsMD (TXMD) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart

TherapeuticsMD Revenue Highlights

Latest Revenue (Q)

$952.00K

Main Segment (Y)

License

Main Geography (Y)

UNITED STATES

TherapeuticsMD Revenue by Period

TherapeuticsMD Revenue by Year

Date	Revenue	Change
2024-12-31	-	-100.00%
2023-12-31	$1.30M	-98.14%
2022-12-31	$69.96M	-19.54%
2021-12-31	$86.95M	34.03%
2020-12-31	$64.87M	30.67%
2019-12-31	$49.65M	208.38%
2018-12-31	$16.10M	-4.04%
2017-12-31	$16.78M	-13.32%
2016-12-31	$19.36M	-3.90%
2015-12-31	$20.14M	34.05%
2014-12-31	$15.03M	71.23%
2013-12-31	$8.78M	129.85%
2012-12-31	$3.82M	82.84%
2011-12-31	$2.09M	4230.79%
2010-12-31	$48.22K	356.21%
2009-12-31	$10.57K	100.00%
2008-12-31	-	100.00%
2007-12-31	-	-100.00%
2006-12-31	$1.01M	7.57%
2005-12-31	$934.52K	50.26%
2004-12-31	$621.93K	42.13%
2003-12-31	$437.59K	52.68%
2002-12-31	$286.60K	-13.82%
2001-12-31	$332.57K	-9.63%
2000-12-31	$368.02K	71.82%
1999-12-31	$214.19K	10.42%
1998-12-31	$193.97K	0.45%
1997-12-31	$193.10K	-20.88%
1996-12-31	$244.05K	24.62%
1995-12-31	$195.83K	-0.48%
1994-12-31	$196.78K	-2.19%
1993-12-31	$201.18K	-

TherapeuticsMD generated - in revenue during NA 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

TherapeuticsMD Revenue by Quarter

Date	Revenue	Change
2025-06-30	$952.00K	142.24%
2025-03-31	$393.00K	-41.08%
2024-12-31	$667.00K	21.94%
2024-09-30	$547.00K	133.76%
2024-06-30	$234.00K	-25.24%
2024-03-31	$313.00K	-37.65%
2023-12-31	$502.00K	-1047.17%
2023-09-30	$-53.00K	-112.13%
2023-06-30	$437.00K	5.05%
2023-03-31	$416.00K	-63.89%
2022-12-31	$1.15M	-94.49%
2022-09-30	$20.92M	-26.76%
2022-06-30	$28.56M	47.73%
2022-03-31	$19.33M	3.51%
2021-12-31	$18.68M	-26.48%
2021-09-30	$25.41M	10.46%
2021-06-30	$23.00M	15.78%
2021-03-31	$19.87M	-12.01%
2020-12-31	$22.58M	16.72%
2020-09-30	$19.34M	80.76%
2020-06-30	$10.70M	-12.65%
2020-03-31	$12.25M	-22.96%
2019-12-31	$15.90M	-32.96%
2019-09-30	$23.72M	290.20%
2019-06-30	$6.08M	54.03%
2019-03-31	$3.95M	-22.46%
2018-12-31	$5.09M	46.52%
2018-09-30	$3.47M	-7.69%
2018-06-30	$3.76M	-0.28%
2018-03-31	$3.77M	-8.51%
2017-12-31	$4.12M	-6.64%
2017-09-30	$4.42M	3.93%
2017-06-30	$4.25M	6.65%
2017-03-31	$3.99M	-11.19%
2016-12-31	$4.49M	-18.94%
2016-09-30	$5.54M	25.72%
2016-06-30	$4.40M	-10.69%
2016-03-31	$4.93M	-12.43%
2015-12-31	$5.63M	8.47%
2015-09-30	$5.19M	7.06%
2015-06-30	$4.85M	8.33%
2015-03-31	$4.48M	5.11%
2014-12-31	$4.26M	1.71%
2014-09-30	$4.19M	11.58%
2014-06-30	$3.75M	32.55%
2014-03-31	$2.83M	-1.13%
2013-12-31	$2.86M	24.76%
2013-09-30	$2.29M	10.28%
2013-06-30	$2.08M	35.37%
2013-03-31	$1.54M	23.90%
2012-12-31	$1.24M	19.71%
2012-09-30	$1.04M	26.53%
2012-06-30	$819.15K	13.50%
2012-03-31	$721.69K	-65.40%
2011-12-31	$2.09M	99237.00%
2011-09-30	$2.10K	100.00%
2011-06-30	-	100.00%
2011-03-31	-	-100.00%
2010-12-31	$20.36K	-7.94%
2010-09-30	$22.12K	285.77%
2010-06-30	$5.73K	-62.59%
2010-03-31	$15.33K	45.04%
2009-12-31	$10.57K	100.00%
2009-09-30	-	100.00%
2009-06-30	-	100.00%
2009-03-31	-	100.00%
2008-12-31	-	100.00%
2008-09-30	-	100.00%
2008-06-30	-	100.00%
2008-03-31	-	100.00%
2007-12-31	-	-

TherapeuticsMD generated $952.00K in revenue during Q2 2025, up 142.24% compared to the previous quarter, and up 304.15% compared to the same period a year ago.

TherapeuticsMD Revenue Breakdown

TherapeuticsMD Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 18
License	$1.30M	$69.96M	$1.17M	-
Prescription Vitamins	-	-	$5.72M	$15.04M
Product	-	-	$85.78M	-
Annovera	-	-	$37.94M	-
IMVEXXY R	-	-	-	$1.06M

TherapeuticsMD's latest annual revenue breakdown by segment (product or service), as of Dec 23: License (100.00%).

Quarterly Revenue by Product

Product/Service	Sep 24	Jun 24	Mar 24	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Jun 19	Mar 19	Dec 18	Sep 18
License and Service	$547.00K	$234.00K	$313.00K	$416.00K	-	-	-	-	-	-	-	-	-	-	-
Annovera	-	-	-	-	$10.41M	$18.27M	$8.51M	$7.83M	$11.81M	$9.55M	-	-	-	-	-
Imvexxy	-	-	-	-	$6.95M	$6.67M	$9.84M	-	-	-	-	-	-	-	-
License And Service	-	-	-	-	-	$65.00K	$419.00K	-	-	-	-	-	-	-	-
Prescription Vitamins	-	-	-	-	$892.00K	$904.00K	$875.00K	$1.50M	$1.35M	$1.45M	$1.43M	$2.82M	$1.94M	$4.24M	$3.26M
Product	-	-	-	-	$20.92M	$28.50M	$18.91M	$18.68M	$24.47M	$23.00M	$19.63M	-	-	-	-
License	-	-	-	-	-	-	-	-	$937.00K	-	$234.00K	-	-	-	-
Bijuva	-	-	-	-	-	-	-	-	-	$2.16M	-	-	-	-	-
IMVEXXY	-	-	-	-	-	-	-	-	-	-	$7.01M	$3.12M	$2.01M	-	-
ANNOVERA	-	-	-	-	-	-	-	-	-	-	$8.75M	-	-	-	-
BIJUVA	-	-	-	-	-	-	-	-	-	-	$2.44M	$134.28K	-	-	-
IMVEXXY R	-	-	-	-	-	-	-	-	-	-	-	-	-	$846.13K	-
IMVEXXY TM	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$212.08K

TherapeuticsMD's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: License and Service (100.00%).

TherapeuticsMD Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 24
Non-US	$638.00K
UNITED STATES	$1.12M

TherapeuticsMD's latest annual revenue breakdown by geography, as of Dec 24: UNITED STATES (63.77%), and Non-US (36.23%).

Quarterly Revenue by Country

Country	Jun 25	Mar 25	Mar 23	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Jun 19	Mar 19	Dec 18	Sep 18
UNITED STATES	$642.00K	$174.00K	-	-	-	-	-	-	-	-	-	-	-	-
Non-US	$310.00K	$219.00K	-	-	-	-	-	-	-	-	-	-	-	-
License and Service	-	-	$416.00K	-	-	-	-	-	-	-	-	-	-	-
Prescription Vitamins	-	-	-	$892.00K	$904.00K	$875.00K	$1.50M	$1.35M	$1.45M	$1.43M	$2.82M	$1.94M	$4.24M	$3.26M
Annovera	-	-	-	$10.41M	$18.27M	$8.51M	$7.83M	$11.81M	$9.55M	-	-	-	-	-
Imvexxy	-	-	-	$6.95M	$6.67M	$9.84M	-	-	-	-	-	-	-	-
License And Service	-	-	-	-	$65.00K	$419.00K	-	-	-	-	-	-	-	-
Product	-	-	-	$20.92M	$28.50M	$18.91M	$18.68M	$24.47M	$23.00M	$19.63M	-	-	-	-
License	-	-	-	-	-	-	-	$937.00K	-	$234.00K	-	-	-	-
Bijuva	-	-	-	-	-	-	-	-	$2.16M	-	-	-	-	-
ANNOVERA	-	-	-	-	-	-	-	-	-	$8.75M	-	-	-	-
BIJUVA	-	-	-	-	-	-	-	-	-	$2.44M	$134.28K	-	-	-
IMVEXXY	-	-	-	-	-	-	-	-	-	$7.01M	$3.12M	$2.01M	-	-
IMVEXXY R	-	-	-	-	-	-	-	-	-	-	-	-	$846.13K	-
IMVEXXY TM	-	-	-	-	-	-	-	-	-	-	-	-	-	$212.08K

TherapeuticsMD's latest quarterly revenue breakdown by geography, as of Jun 25: UNITED STATES (67.44%), and Non-US (32.56%).

TherapeuticsMD Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
RDGT	Ridgetech	$154.54M	$35.70M
FLGC	Flora Growth	$59.51M	$11.79M
BFRI	Biofrontera	$37.30M	$8.59M
BOLT	Bolt Biotherapeutics	$7.69M	$1.22M
SINT	Sintx	$2.89M	$369.00K
IMRN	Immuron	$1.80M	$2.36M
ACXP	Acurx Pharmaceuticals	-	-
TXMD	TherapeuticsMD	-	$952.00K
GELS	Gelteq Limited Ordinary Shares	-	-
CHEK	Check-Cap	-	-

TXMD Revenue FAQ

What is TherapeuticsMD’s yearly revenue?

TherapeuticsMD's yearly revenue for 2024 was $0, representing a decrease of -100.00% compared to 2023. The company's yearly revenue for 2023 was $1.3M, representing a decrease of -98.14% compared to 2022. TXMD's yearly revenue for 2022 was $69.96M, representing a decrease of -19.54% compared to 2021.

What is TherapeuticsMD’s quarterly revenue?

TherapeuticsMD's quarterly revenue for Q2 2025 was $952K, a 142.24% increase from the previous quarter (Q1 2025), and a 306.84% increase year-over-year (Q2 2024). The company's quarterly revenue for Q1 2025 was $393K, a -41.08% decrease from the previous quarter (Q4 2024), and a 25.56% increase year-over-year (Q1 2024). TXMD's quarterly revenue for Q4 2024 was $667K, a 21.94% increase from the previous quarter (Q3 2024), and a 32.87% increase year-over-year (Q4 2023).

What is TherapeuticsMD’s revenue growth rate?

TherapeuticsMD's revenue growth rate for the last 3 years (2022-2024) was -100.00%, and for the last 5 years (2020-2024) was -100.00%.

What are TherapeuticsMD’s revenue streams?

TherapeuticsMD's revenue streams in c 23 are License

What is TherapeuticsMD’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of TherapeuticsMD was License. This segment made a revenue of $1.3M, representing 100.00% of the company's total revenue.